Moderna
MRNA
#1287
Rank
NZ$30.49 B
Marketcap
NZ$76.89
Share price
-1.24%
Change (1 day)
69.32%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: NZ$30.49 Billion

As of May 2026 Moderna has a market cap of NZ$30.49 Billion. This makes Moderna the world's 1287th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$30.49 B44.87%
2025NZ$21.04 B-23.13%
2024NZ$27.38 B-54.33%
2023NZ$59.95 B-44.83%
2022NZ$108.68 B-27.91%
2021NZ$150.76 B163.14%
2020NZ$57.29 B486.18%
2019NZ$9.77 B30.58%
2018NZ$7.48 B

End of Day market cap according to different sources

On May 1st, 2026 the market cap of Moderna was reported to be:

NZ$30.49 Billion
by Nasdaq info icon info icon
NZ$30.49 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$926.87 B 2,939.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$473.98 B 1,454.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
NZ$469.49 B 1,439.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
NZ$0.95 B-96.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
NZ$5.04 B-83.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
NZ$1.41 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$66.96 B 119.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
NZ$17.75 B-41.78%๐Ÿ‡บ๐Ÿ‡ธ USA